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Inactivation of the Retinoblastoma Gene in Human Lymphoid Neoplasms
By Ann M. Ginsberg T pressor genes contributes to carcinogenesis stems from the two-event model fostered by Knudsen, based on his observations of inheritable susceptibility to retinoblastoma (Rb).' Genetic linkage analysis localized the Rb susceptibility gene to chromosome 13q14.2-5 The Rb gene encodes a nuclear phosphoprotein whose phosphorylation is regulated in a cell-cycle-specific manner."9 Inactivation of the Rb gene has been implicated in the pathogenesis of a variety of human solid tumors, including osteosarcoma and soft tissue sarcoma^^""'^ and carcinomas of the brea~t,'~.'~ and bladder? as well as Rb. Although cancer development is a multifactorial process, these findings suggest that common genetic abnormalities occur in many different cancer types and may help explain the deregulated growth control associated with malignancy. Lymphoid neoplasms represent a broad variety of disease states composed of clonally expanded populations of T or B lymphocytes. The discovery of activation of genes, particularly as a consequence of chromosomal translocation, in lymphoid neoplasms has focused attention on the role of oncogene products and other growth-promoting cellular constituents in the pathogenesis of these diseases. However, little information exists regarding the possible role of inactivation of tumor-suppressor genes in lymphoma or leukemia. To extend the observations of Rb in solid tumors, we used DNA and RNA blot hybridization analyses to survey primary tissues and cell lines of T-and B-cell neoplasia for derangements of the Rb gene. Using these techniques we have identified a significant proportion of primary lymphoid neoplasms with derangements of the Rb locus. As shown in studies of various carcinomas and sarcomas, nucleic acid hybridization methods detect only a subset of the tumors carrying mutations at the Rb locus. Studies of the Rb protein should show an even higher percent of lymphoid neoplasms associated with Rb mutations. Thus, our findings support a role for inactivation of the Rb gene product in the development of human lymphoid malignancies.
MATERIALS AND METHODS
Primary cases of malignant lymphoma and leukemia were collected and stored frozen as previously described." Cell lines used in this study include the T-cell acute lymphoblastic leukemia (T-ALL) lines, HSB-2 (American Type Cells and tissues. cDNA probes, designated Rb0.9 and Rb3.8 and representing 5' and 3' portions of the Rb cDNA, respectively, were the generous gifts of Dr Stephen Friend (Boston, MA) and are depicted in Fig 1A (see also reference 4 ). Chicken p-tubulinzs and actinz6 probes were the kind gifts of Dr Andrew Larner (Bethesda, MD). Probes were labeled with ("P) by the random primer method" using the Bethesda Research Laboratories (BRL) Random Primers DNA Labeling System (BRL, Life Technologies, Inc, Gaithersburg, MD) essentially according to the manufacturer's directions, except that additional (Y . "P-dCTP was sometimes added to increase probe specific activity. Probes were labeled to specific activities of 1 to 3 x io9 cpm/pg. .
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RESULTS
We analyzed the Rb locus in a variety of lymphomas and leukemias, examining both primary case material and cell lines for deletions or mutations in the DNA and for alterations in Rb RNA expression. Figure 1 presents Southern blot and Northern blot hybridization data for five T-ALL cell lines: CEM, Jurkat, Molt-4, 8402, and HSB-2. HSB-2 shows a homozygous deletion with the 3' cDNA probe, Rb3.8, involving the lo-, 6.2-, 4.3-(partially lost only, due to comigration of bands; see also reference 28), and 2.1-kb HindIII-generated restriction fragments, which encode exons 18 through 27 (Fig 1A and B) . This deletion has occurred despite retention of two cytogenetically normal chromosomes 13, a finding independently confirmed by others.** The other four cell lines show the germline configuration of the Rb locus when probed with both 5' and 3' probes encoding the entire cDNA sequence4 (Fig 1) . Northern blot analysis of total cellular RNA from these cell lines (Fig 1C) showed abundant wild-type sized, 4.7-kb transcripts in CEM, Molt-4, and 8402 cells. In HSB-2, several hybridizing species are seen: a minor band at approximately 6 kb representing an apparently unpolyadenylated form,= and several smaller species, the most abundant of which is approximately 1.8 kb. SB, a B-lymphoblastoid cell line derived from the same patient as the HSB-2 cell line, shows a germline DNA configuration at the Rb locus and abundant 4.7-kb Rb RNA ( Figs 1C and 2A, and data not shown) . Therefore, the deletion in the Rb locus in HSB-2 cells appears to be tumor specific. In Jurkat cells, which do not have a detectable deletion by Southern blot analysis (Fig IB) , little or no Rb message was observed in Northern blots with either cDNA probe, Rb3.8, or Rb0.9 (Fig 1 and data not shown) . Two of five T-ALL cell lines examined (HSB-2 and Jurkat), therefore, show markedly decreased to no detectable wild-type Rb expression at the RNA level.
T-ALL.
We next examined DNA from 26 primary cases of T-ALL by Southern hybridization analysis, using multiple restriction enzymes and probing with both Rb3.8 and Rb0.9. One case, no. 1709, demonstrated a germline configuration when probed with Rb0.9 (data not shown), but showed a 3' deletion when probed with Rb3.8, identical at this level of analysis to the 3' Rb deletion present in HSB-2 cells. This deletion is seen as a loss of the greater than 19-and 10.8-kb bands in BamHI-digested DNA, the 6.5, 4.1-, 3.0-, and 2.3-kb bands in EcoRI-digested DNA, and the lo-, 6.2-, 4.3-(partially lost, see above), and 2.1-kb bands in HindIIIdigested genomic DNA (Fig 2A and data not shown) . Therefore, this primary case, like the HSB-2 cell line, has apparently deleted exons 18 through 27 from both chromosomes. The remaining 25 cases all showed a germline DNA configuration. Material was available to perform Northern blot analysis on seven T-ALL cases, including case no. 1709, as well as two for whom DNA was not available for Southern analysis. No Rb-hybridizing RNA species were detectable by Northern blot analysis in case no. 1709 ( Fig  2B) . The six other cases all demonstrated significant and approximately equivalent amounts of Rb 4.7-kb transcript ( Fig 2B and data not shown) . Thus, 1 of 26 primary cases of T A L L showed an abnormal Rb locus.
Chronic lymphocytic leukemia (CLL)lwell-differentiated lymphoma (WDL). We performed Southern blot hybridization analysis of genomic DNA extracted from 40 primary cases of CLLWDL. One case, no. 1901, demonstrated a 5' deletion at the Rb locus in both alleles, represented by loss of the lo-, 8.7-, and 3.4-kb bands in EcoRI-digested genomic DNA. The 2.8-kb band appeared to be present in only one copy (Fig 3A) . The 39 other CLL cases showed a germline DNA configuration at the Rb locus when probed with both Rb3.8 and Rb0.9. Three of these 39 cases, plus two additional cases of CLL, were analyzed by Northern blot hybridization. One of these five cases, no. 1483, synthesized markedly reduced levels of the Rb 4.7-kb transcript, despite showing germline DNA configuration by Southern analysis with both cDNA probes, using EcoRI-, HindIII-, and BamHI-digested genomic DNA (Fig 3 and  data not shown) . In the other four cases significant amounts of an apparently normal 4.7-kb Rb transcript were detected (Fig 3B) . These five cases were all similarly estimated to contain at least 70% to 80% tumor cells by immunophenotypic and flow cytometric analysis.
We analyzed 15 primary cases of IDL, a low-grade B-cell neop l a~m ,~~,~' by Southern blot hybridization. One case, no. 1869, demonstrated a deletion in the Rb locus. As seen in Fig 4A, a Southern blot of HindIII-digested no. 1869 DNA probed with Rb3.8 revealed that all Rb3.8-hybridizing bands showed decreased signal intensity, consistent with loss of exons 10 through 27 from at least one chromosome in the cells of this patient's neoplasm. Because this is primary patient material, one cannot be sure whether the relatively faint signals present at germline band sizes represent Rb DNA from one undeleted chromosome in the malignant cells or DNA contributed by admixed benign cells. Flow cytometric analysis of both this case and case no.
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2086 (see Fig 4A) demonstrated that the malignant cells represent 70% to 80% of the total cell population in each of these tumors. Rehybridization with a control probe from chromosome 18 (see lower panel of Fig 4A) showed equivalent loading and integrity of DNA samples on this Southern blot. Hybridization with Rb0.9 demonstrated 5'
Rb DNA sequences in a germline configuration. Assessment of relative signal intensity of the 5' bands is rendered difficult by cross-hybridization of Rb0.9 probe sequences to repetitive sequences in the genomic DNA.4 Therefore, we cannot conclude with certainty whether one chromosomal copy of these 5' sequence bands is deleted as well. (Figs 1 and 2 , and unpublished data) were also examined and shown to contain Rb DNA in the germline configuration and significant amounts of 4.7-kb Rb transcript.
B-cell lines.

DISCUSSION
We have examined a total of nine lymphoid cell lines and 85 primary cases of lymphoid malignancies for alterations in Rb DNA and/or Rb RNA expression. Two of the cell lines and four of the primary cases were abnormal in these use only. assays. In view of the relatively insensitive nature of these nucleic acid hybridization techniques, these results show a significant mutation frequency in the Rb locus in both lowand high-grade lymphoid neoplasms. Nucleic acid hybridization studies of a variety of human solid tumors have demonstrated alterations in Rb DNA or RNA in only a small percent of primary cases (eg, studies of lung, breast, and bladder cancers), whereas subsequent studies of Rb protein in these tumors have frequently shown a much higher frequency of Rb abnormalities." Therefore, it is of use only.
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It has been proposed'*"'"* that inactivation of the Rb locus may contribute to the progression rather than initiation of many solid tumors. Thus, it is noteworthy that of three primary cases of low-grade lymphomas with abnormalities in Rb, two exhibited histologic features considered to be poor prognostic indicator^.'^.^^.'^ Patient no. 1869 exhibited IDL in blast crisis and patient no. 1483 exhibited WDL with an unusually high mitotic rate. Clinically, both of these patients did exceptionally poorly* (the third patient, no. 1901, died shortly after his diagnosis of CLL, but of causes unrelated to this disease). Furthermore, T-ALL, a highgrade lymphoid neoplasm, demonstrated Rb alterations by Northern blot analysis in one of seven primary cases and two of five cell lines. Therefore, our findings suggest that mutational inactivation of the Rb locus contributes to the progression of lymphoid neoplasms from low-grade to aggressive subtypes.
Studies examining primary case material for the absence of DNA or RNA sequences are complicated both by variable amounts of nucleic acid degradation and by the presence in these specimens of admixed normal cells. We attempted to minimize these problems by excluding any samples that demonstrated significant amounts of degradation and by examining lymphomas and leukemias that characteristically contain relatively few admixed benign cells. The use of in situ techniques will lessen the endemic problem of signal contribution from contaminating benign cells by helping to delineate whether small but detectable amounts of Rb RNA seen in patient materials (eg, see case no. 1483) represent contaminating RNA from admixed benign cells, Rb expression in only a subset of malignant cells, or markedly decreased amounts of normal gene transcript being synthesized by all malignant cells.
We have shown mutations at the Rb locus by Southern analysis in 1 of 5 high-grade IymphomaAeukemia (T-ALL) cell lines, in 1 of 26 primary cases of high-grade lymphoma/ leukemia, and in 1 of 55 primary cases of low-grade B-cell malignancies (CLL/WDL and IDL). By Northern analysis, we detected markedly decreased or no Rb transcripts in 2 of 5 high-grade leukemia cell lines, 1 of 7 primary cases of high-grade lymphomaAeukemia, and 2 of 11 low-grade B-cell malignancies. Future studies using in situ and antibody techniques should show a role for abnormal Rb expression in more cases of lymphoid malignancies and help to test the model that inactivation of Rb contributes to progression in human lymphoma and leukemia.
